Bayer R&D Draws on Tobacco | Chemical & Engineering News
Volume 86 Issue 25 | p. 17 | Concentrates
Issue Date: June 23, 2008

Bayer R&D Draws on Tobacco

Department: Business
Bayer scientist prepares tobacco leaves for protein extraction.
Credit: Bayer

Bayer and its subsidiary Icon Genetics have opened a pilot facility that employs a new process for producing biotech drugs in tobacco plants. The facility, in Halle, Germany, offers potential to speed up development both of active ingredients produced in tobacco and new treatment approaches. According to Bayer, tobacco plants can yield proteins rapidly and in high quantities. The pilot facility already has its first candidate: a protein being developed as a patient-specific vaccine for non-Hodgkin's lymphoma.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment